188 related articles for article (PubMed ID: 15942435)
1. Clinical outcomes and prognostic factors for patients with early esophageal squamous cell carcinoma treated with definitive radiation therapy alone.
Ishikawa H; Sakurai H; Yamakawa M; Saito Y; Nakayama Y; Kitamoto Y; Okamoto M; Harada K; Hasegawa M; Nakano T
J Clin Gastroenterol; 2005 Jul; 39(6):495-500. PubMed ID: 15942435
[TBL] [Abstract][Full Text] [Related]
2. Radiation therapy alone for stage I (UICC T1N0M0) squamous cell carcinoma of the esophagus: indications for surgery or combined chemoradiotherapy.
Ishikawa H; Sakurai H; Tamaki Y; Nonaka T; Yamakawa M; Saito Y; Kitamoto Y; Higuchi K; Hasegawa M; Nakano T
J Gastroenterol Hepatol; 2006 Aug; 21(8):1290-6. PubMed ID: 16872312
[TBL] [Abstract][Full Text] [Related]
3. Multi-institutional randomized trial of external radiotherapy with and without intraluminal brachytherapy for esophageal cancer in Japan. Japanese Society of Therapeutic Radiology and Oncology (JASTRO) Study Group.
Okawa T; Dokiya T; Nishio M; Hishikawa Y; Morita K
Int J Radiat Oncol Biol Phys; 1999 Oct; 45(3):623-8. PubMed ID: 10524414
[TBL] [Abstract][Full Text] [Related]
4. Esophageal cancer treated with radiotherapy: impact of total treatment time and fractionation.
Nishimura Y; Ono K; Tsutsui K; Oya N; Okajima K; Hiraoka M; Abe M
Int J Radiat Oncol Biol Phys; 1994 Dec; 30(5):1099-105. PubMed ID: 7961017
[TBL] [Abstract][Full Text] [Related]
5. Treatment results of chemoradiotherapy for clinical stage I (T1N0M0) esophageal carcinoma.
Yamada K; Murakami M; Okamoto Y; Okuno Y; Nakajima T; Kusumi F; Takakuwa H; Matsusue S
Int J Radiat Oncol Biol Phys; 2006 Mar; 64(4):1106-11. PubMed ID: 16504758
[TBL] [Abstract][Full Text] [Related]
6. Results of external irradiation and low-dose-rate intraluminal brachytherapy for esophageal cancer.
Someya M; Sakata K; Saito A; Nagakura H; Oouchi A; Hareyama M
Acta Oncol; 2002; 41(1):63-8. PubMed ID: 11990521
[TBL] [Abstract][Full Text] [Related]
7. Salvage high-dose-rate brachytherapy for esophageal cancer in previously irradiated patients: A retrospective analysis.
Wong Hee Kam S; Rivera S; Hennequin C; Lourenço N; Chirica M; Munoz-Bongrand N; Gornet JM; Quéro L
Brachytherapy; 2015; 14(4):531-6. PubMed ID: 25906950
[TBL] [Abstract][Full Text] [Related]
8. Epidermoid carcinoma of the anal canal. Results of curative-intent radiation therapy in a series of 270 patients.
Touboul E; Schlienger M; Buffat L; Lefkopoulos D; Pène F; Parc R; Tiret E; Gallot D; Malafosse M; Laugier A
Cancer; 1994 Mar; 73(6):1569-79. PubMed ID: 8156483
[TBL] [Abstract][Full Text] [Related]
9. Definitive radiotherapy for carcinoma of the vagina: outcome and prognostic factors.
Chyle V; Zagars GK; Wheeler JA; Wharton JT; Delclos L
Int J Radiat Oncol Biol Phys; 1996 Jul; 35(5):891-905. PubMed ID: 8751398
[TBL] [Abstract][Full Text] [Related]
10. External beam radiation therapy followed by high-dose-rate brachytherapy for inoperable superficial esophageal carcinoma.
Pasquier D; Mirabel X; Adenis A; Rezvoy N; Hecquet G; Fournier C; Coche-Dequeant B; Prevost B; Castelain B; Lartigau E
Int J Radiat Oncol Biol Phys; 2006 Aug; 65(5):1456-61. PubMed ID: 16863928
[TBL] [Abstract][Full Text] [Related]
11. Radiation therapy for superficial esophageal cancer: a comparison of radiotherapy methods.
Nemoto K; Yamada S; Hareyama M; Nagakura H; Hirokawa Y
Int J Radiat Oncol Biol Phys; 2001 Jul; 50(3):639-44. PubMed ID: 11395230
[TBL] [Abstract][Full Text] [Related]
12. Comparison of efficacy and safety of low-dose-rate vs. high-dose-rate intraluminal brachytherapy boost in patients with superficial esophageal cancer.
Tamaki T; Ishikawa H; Takahashi T; Tamaki Y; Kitamoto Y; Okamoto M; Noda SE; Katoh H; Shirai K; Sakurai H; Nakano T
Brachytherapy; 2012; 11(2):130-6. PubMed ID: 21700506
[TBL] [Abstract][Full Text] [Related]
13. Prospective randomized trial of HDR brachytherapy as a sole modality in palliation of advanced esophageal carcinoma--an International Atomic Energy Agency study.
Sur RK; Levin CV; Donde B; Sharma V; Miszczyk L; Nag S
Int J Radiat Oncol Biol Phys; 2002 May; 53(1):127-33. PubMed ID: 12007950
[TBL] [Abstract][Full Text] [Related]
14. High dose rate brachytherapy for superficial cancer of the esophagus.
Maingon P; d'Hombres A; Truc G; Barillot I; Michiels C; Bedenne L; Horiot JC
Int J Radiat Oncol Biol Phys; 2000 Jan; 46(1):71-6. PubMed ID: 10656375
[TBL] [Abstract][Full Text] [Related]
15. High dose radiation with chemotherapy followed by salvage esophagectomy among patients with locally advanced esophageal squamous cell carcinoma.
Lertbutsayanukul C; Tharavej C; Klaikeaw N; Prayongrat A; Lowanitchai C; Sriuranpong V
Thorac Cancer; 2017 May; 8(3):219-228. PubMed ID: 28322515
[TBL] [Abstract][Full Text] [Related]
16. Influence of radiation dose and predicted tumor invasion depth on local recurrence after definitive chemoradiotherapy for stage 0-I esophageal squamous cell carcinoma: a propensity score-weighted, retrospective, observational study.
Ikawa T; Ishihara R; Matsueda K; Konishi K; Yamamoto S; Morimoto M; Kanayama N; Teshima T
BMC Cancer; 2022 Mar; 22(1):301. PubMed ID: 35313853
[TBL] [Abstract][Full Text] [Related]
17. Optimum fractionation for high-dose-rate endoesophageal brachytherapy following external irradiation of early stage esophageal cancer.
Akagi Y; Hirokawa Y; Kagemoto M; Matsuura K; Ito A; Fujita K; Kenjo M; Kiriu H; Ito K
Int J Radiat Oncol Biol Phys; 1999 Feb; 43(3):525-30. PubMed ID: 10078632
[TBL] [Abstract][Full Text] [Related]
18. High-dose-rate brachytherapy boost following concurrent chemoradiotherapy for esophageal carcinoma.
Yorozu A; Dokiya T; Oki Y
Int J Radiat Oncol Biol Phys; 1999 Sep; 45(2):271-5. PubMed ID: 10487545
[TBL] [Abstract][Full Text] [Related]
19. Treatment of superficial esophageal cancer by external radiation therapy alone: results of a multi-institutional experience.
Nemoto K; Matsumoto Y; Yamakawa M; Jo S; Ito Y; Oguchi M; Kokubo N; Nishimura Y; Yamada S; Okawa T
Int J Radiat Oncol Biol Phys; 2000 Mar; 46(4):921-5. PubMed ID: 10705014
[TBL] [Abstract][Full Text] [Related]
20. Interstitial brachytherapy for stage I and II squamous cell carcinoma of the oral tongue: factors influencing local control and soft tissue complications.
Fujita M; Hirokawa Y; Kashiwado K; Akagi Y; Kashimoto K; Kiriu H; Matsuura K; Ito K
Int J Radiat Oncol Biol Phys; 1999 Jul; 44(4):767-75. PubMed ID: 10386633
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
